Last reviewed · How we verify
NCT03438812
Dehydroepiandrosterone Maintain Mitochondrial Quality of Cumulus Cells in Poor Ovarian Responders
NA trial testing dehydroepiandrosterone (DHEA) in Poor Responders in 66 participants. Completed in 31 December 2019.
31 December 2019
Quick facts
| Lead sponsor | Kaohsiung Veterans General Hospital. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 66 |
| Start date | 6 September 2017 |
| Primary completion | 31 December 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- dehydroepiandrosterone (DHEA) — full drug profile →
Conditions studied
- Poor Responders — all drugs for Poor Responders →
- Dehydroepiandrosterone — all drugs for Dehydroepiandrosterone →
Sponsor
Kaohsiung Veterans General Hospital.
Who can join
Adults 25 to 45, female only, with Poor Responders or Dehydroepiandrosterone. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate whether the DHEA supplementation could improve mitochondrial quality in poor ovarian responders
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Phosphoglycerate mutase family member 5 maintains oocyte quality via mitochondrial dynamic rearrangement during aging.
Li CJ, Lin LT, Tsai HW, Wen ZH, et al · · 2022 · cited 48× · PMID 34995407 · DOI 10.1111/acel.13546 -
Dehydroepiandrosterone Shifts Energy Metabolism to Increase Mitochondrial Biogenesis in Female Fertility with Advancing Age.
Li CJ, Lin LT, Tsui KH. · · 2021 · cited 26× · PMID 34371958 · DOI 10.3390/nu13072449 -
Dehydroepiandrosterone Ameliorates Abnormal Mitochondrial Dynamics and Mitophagy of Cumulus Cells in Poor Ovarian Responders.
Li CJ, Chen SN, Lin LT, Chern CU, et al · · 2018 · cited 20× · PMID 30241351 · DOI 10.3390/jcm7100293 -
Abstracts for 2018 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference.
· 2018 · PMID 30317467 · DOI 10.1007/s10815-018-1321-3
Verify or expand the search:
- PubMed search for NCT03438812
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Poor Responders
Currently open trials in the same condition.
- NCT06663930 — New Approach for Ovarian PRP Injection for Poor Responders · active not recruiting
- NCT04487925 — Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders · Phase 4 · recruiting
Other Kaohsiung Veterans General Hospital. trials
Trials by the same sponsor.
- NCT07278024 — Postbiotic Intervention on Vaginal Microbiota · NA · completed
- NCT07051265 — Effect of Transcutaneous Electrical Nerve Stimulation or Acupressure on Pain in Patients With Head and Neck Cancer · NA · enrolling by invitation
- NCT06777758 — Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments · Phase 4 · recruiting
- NCT06803199 — Effects of LH and FSH on Metabolic Regulation in Cumulus Cells · NA · recruiting
- NCT06946888 — Effects of Acupressure on Nurses' Psychological Distress, Depression, Job Stress, Occupational Burnout, and Resilience · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03438812 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kaohsiung Veterans General Hospital.
- Last refreshed: 18 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03438812.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing